| Mycobacterium Abscessus Treatment Market’s 5.2% CAGR: Top Companies in 2026 |
|
| According to a newly published market research report by 24LifeSciences, the global Mycobacterium Abscessus Treatment market was valued at USD 320 million in 2024 and is projected to reach USD 510 million by 2032, growing at a compound annual growth |
| read more |
|
|
| Starch-based Packaging Material Market Set to Hit USD 11.36 Billion by 2032 at 7.3% CAGR |
|
| Global starch-based packaging material market size was valued at USD 6.72 billion in 2024. The market is projected to grow from USD 7.21 billion in 2025 to USD 11.36 billion by 2032, exhibiting a CAGR of 7.3% during the forecast period. The influence |
| read more |
|
|
| Global Medicinal Capsules Market to Reach USD 4.1 Billion by 2032 |
|
| According to a newly published market research report by 24LifeSciences, global medicinal capsules market was valued at USD 2.5 billion in 2025 and is projected to reach USD 4.1 billion by 2034, growing at a compound annual growth rate (CAGR) of 5.3% |
| read more |
|
|
| Who Dominates the Anemia and Vitamin Test Market ? Top Players Revealed |
|
| According to a newly published market research report by 24LifeSciences, global anemia and vitamin test market was valued at USD 2.8 billion in 2023 and is projected to reach USD 5.7 billion by 2031, growing at a compound annual growth rate (CAGR) of |
| read more |
|
|
| Insomnia Therapeutics Drugs Market to Reach USD 3.6 Billion by 2032 | CAGR 3.7% |
|
| According to a newly published market research report by 24LifeSciences, global insomnia therapeutics drugs market was valued at USD 2.86 billion in 2024 and is projected to reach USD 3.66 billion by 2031, growing at a compound annual growth rate (CA |
| read more |
|
|
| What Is the Future of Eye Fatigue Eye Drops Market ? 2026–2034 Outlook |
|
| According to a newly published market research report by 24LifeSciences, global eye fatigue eye drops market was valued at USD 1.2 billion in 2025 and is projected to reach USD 2.1 billion by 2034, growing at a compound annual growth rate (CAGR) of 6 |
| read more |
|
|
